Ann Dermatol.  2015 Dec;27(6):751-755. 10.5021/ad.2015.27.6.751.

Hypopigmentation Induced by Frequent Low-Fluence, Large-Spot-Size QS Nd:YAG Laser Treatments

Affiliations
  • 1National Skin Centre, Singapore, Singapore. yswong@nsc.gov.sg

Abstract

The Q-switched 1064-nm neodymium-doped yttrium aluminum garnet (QS 1064-nm Nd:YAG) laser is increasingly used for nonablative skin rejuvenation or "laser toning" for melasma. Multiple and frequent low-fluence, large-spot-size treatments are used to achieve laser toning, and these treatments are associated with the development of macular hypopigmentation as a complication. We present a case series of three patients who developed guttate hypomelanotic macules on the face after receiving laser toning treatment with QS 1064-nm Nd:YAG.

Keyword

Laser-induced hypopigmentation; Laser toning; QS 1064-nm Nd:YAG

MeSH Terms

Aluminum
Humans
Hypopigmentation*
Melanosis
Rejuvenation
Skin
Yttrium
Aluminum
Yttrium

Figure

  • Fig. 1 (A) Guttate hypopigmented macules on the face of the patient in case 1. (B) Case 1 patient after topical treatment for 2 years. (C) Areas showing preserved basal melanin pigmentation (left side of the epidermis) and decreased basal melanin pigmentation (right side of the epidermis) (Fontana-Masson stain, ×100). (D) In areas with preserved basal melanin pigmentation, the number of melanocytes was normal and the dendritic processes were prominent (Melanoma Triple Cocktail [human melanoma black 45+melan-A+tyrosinase], ×200). (E) Hypopigmented areas showed decrease in the number of melanocytes; their dendritic processes were also markedly reduced (Melanoma Triple Cocktail, ×200). (F) The number of melanocytes was preserved in the pigmented areas (microphthalmia transcription factor stain [MITF], ×200). (G) The number of melanocytes was decreased in the hypopigmented areas (MITF, ×200).

  • Fig. 2 Guttate hypopigmented macules on the face of the patient in case 2.

  • Fig. 3 Guttate hypopigmented macules on the face of the patient in case 3.


Cited by  2 articles

Analysis of Clinical Features and Treatment Outcomes Using 1,064-nm Nd-YAG Laser with Topical Hydroquinone in Patients with Riehl's Melanosis: A Retrospective Study in 10 Patients
Chong Won Choi, Gwanghyun Jo, Dong Hun Lee, Seong Jin Jo, Cheol Lee, Je-Ho Mun
Ann Dermatol. 2019;31(2):127-132.    doi: 10.5021/ad.2019.31.2.127.

Treatment of Laser Therapy-Induced Punctate Leukoderma Using a 308-nm Excimer Laser
Han Mi Jung, Hyub Kim, Ji Hae Lee, Gyong Moon Kim, Jung Min Bae
Ann Dermatol. 2017;29(5):630-632.    doi: 10.5021/ad.2017.29.5.630.


Reference

1. Chan HH, Fung WK, Ying SY, Kono T. An in vivo trial comparing the use of different types of 532 nm Nd:YAG lasers in the treatment of facial lentigines in Oriental patients. Dermatol Surg. 2000; 26:743–749.
Article
2. Kim JH, Kim DH, Kim JH, Lee SG, Kim HS, Park HC, et al. Recovery of pigmentation following selective photothermolysis in adult zebrafish skin: clinical implications for laser toning treatment of melasma. J Cosmet Laser Ther. 2012; 14:277–285.
Article
3. Sim JH, Park YL, Lee JS, Lee SY, Choi WB, Kim HJ, et al. Treatment of melasma by low-fluence 1064 nm Q-switched Nd:YAG laser. J Dermatolog Treat. 2014; 25:212–217.
Article
4. Hwang CY, Lin CS, Tseng ML, Liu HN. Spotted leucoderma after treatment of facial hyperpigmentation on hemodialysis patients employing 1064-nm Q-switched Nd:YAG laser. J Cosmet Laser Ther. 2010; 12:47–50.
Article
5. Ryu HJ, Kim J. A case of mottled hypopigmentation after low-fluence 1,064-nm Q-switched neodymium-doped yttrium aluminum garnet laser therapy. J Cosmet Laser Ther. 2013; 15:290–292.
Article
6. Grimes PE, Bhawan J, Kim J, Chiu M, Lask G. Laser resurfacing-induced hypopigmentation: histologic alterations and repigmentation with topical photochemotherapy. Dermatol Surg. 2001; 27:515–520.
Article
7. Liew SH, Grobbelaar A, Gault D, Sanders R, Green C, Linge C. Hair removal using the ruby laser: clinical efficacy in Fitzpatrick skin types I-V and histological changes in epidermal melanocytes. Br J Dermatol. 1999; 140:1105–1109.
Article
8. Hruza GJ, Dover JS, Flotte TJ, Goetschkes M, Watanabe S, Anderson RR. Q-switched ruby laser irradiation of normal human skin. Histologic and ultrastructural findings. Arch Dermatol. 1991; 127:1799–1805.
Article
9. Kim JE, Chang SE, Yeo UC, Haw S, Kim IH. Histopathological study of the treatment of melasma lesions using a low-fluence Q-switched 1064-nm neodymium:yttrium-aluminiumgarnet laser. Clin Exp Dermatol. 2013; 38:167–171.
Article
10. Kim T, Cho SB, Oh SH. Punctate leucoderma after 1,064-nm Q-switched neodymium-doped yttrium aluminum garnet laser with low-fluence therapy: is it melanocytopenic or melanopenic? Dermatol Surg. 2010; 36:1790–1791.
Article
11. Mun JY, Jeong SY, Kim JH, Han SS, Kim IH. A low fluence Q-switched Nd:YAG laser modifies the 3D structure of melanocyte and ultrastructure of melanosome by subcellular-selective photothermolysis. J Electron Microsc (Tokyo). 2011; 60:11–18.
Article
12. Chan NP, Ho SG, Shek SY, Yeung CK, Chan HH. A case series of facial depigmentation associated with low fluence Q-switched 1,064 nm Nd:YAG laser for skin rejuvenation and melasma. Lasers Surg Med. 2010; 42:712–719.
Article
13. Kim MJ, Kim JS, Cho SB. Punctate leucoderma after melasma treatment using 1064-nm Q-switched Nd:YAG laser with low pulse energy. J Eur Acad Dermatol Venereol. 2009; 23:960–962.
Article
14. Wattanakrai P, Mornchan R, Eimpunth S. Low-fluence Q-switched neodymium-doped yttrium aluminum garnet (1,064 nm) laser for the treatment of facial melasma in Asians. Dermatol Surg. 2010; 36:76–87.
Article
Full Text Links
  • AD
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr